Dolby Laboratories (DLB) Tops Q1 EPS by 2c

Go back to Dolby Laboratories (DLB) Tops Q1 EPS by 2c

Dougherty & Co Upgrades Dolby Laboratories (DLB) to Buy

January 28, 2016 6:59 AM EST

Dougherty & Co upgraded Dolby Laboratories (NYSE: DLB) from Neutral to Buy with a price target of $38.

Analyst Steven Frankel said, "On the heels of a solid Q1 performance where the company posted 3% revenue growth, reiterated its full year guidance, and showed material... More